Syria - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Syria Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases fell by 5% year on year. At 24 Cases in 2019, the country was ranked number 216 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. Syria is overtaken by Togo, which was ranked number 215 with 25 Cases and is followed by Bulgaria with 23 Cases. India ranked the highest with 66,255 Cases in 2019, that is +13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia was the worst growing country at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 24.00 |
| 2018 | 22.00 |
| 2017 | 15.00 |
| 2016 | 23.00 |
| 2015 | 4.00 |
How does Syria rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 215 |
#215
Togo
|
25 | 2019 | +4.2 % | +22.7 % | View data | |
| 216 |
#216
Syria
|
24 | 2019 | +9.1 % | -5.0 % | View data | |
| 217 |
#217
Bulgaria
|
23 | 2019 | -8.0 % | -12.2 % | View data | |